Market Overview

From Earlier: Leerink Swann Downgrades Pharmacyclics, Inc. to Market Perform

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for PCYC

DateFirmActionFromTo
Mar 2015NomuraDowngradesBuyNeutral
Mar 2015Leerink SwannDowngradesOutperformMarket Perform
Mar 2015BTIG ResearchDowngradesBuyNeutral

View More Analyst Ratings for PCYC
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (PCYC)

Get Benzinga's Newsletters